A PE-backed medical technology company in Oxford specialising in organ preservation has completed a $142m primary and ...
Financing strengthens OrganOx to expand its leadership position in organ technologyOXFORD, United Kingdom and MADISON, N.J., Feb. 24, 2025., a leading organ medical technology company, successfully co ...
OrganOx announced today that it completed a $142 million primary and secondary equity financing to accelerate growth ...
GlobalData on MSN5d
OrganOx raises $142m to accelerate growth of metra platform technologyOrganOx 's metra normothermic machine perfusion platform gained approval in Australia, Europe, Canada, and the US.
OrganOx, with its system for actively preserving viable donor tissue ahead of a transplant procedure, has raised $142 million ...
New investor HealthQuest Capital led the oversubscribed financing round, with participation from current investors of the company, Lauxera Capital Partners and BGF. Other new investors included ...
Axios on MSN4d
OrganOx raises $142 million to help liver transplantsOrganOx, a British developer of technologies to maintain organs for transplant, raised $142m in primary and secondary funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback